Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway - Tao, Na-Na; Zhou, Hong-Zhong; Tang, Hua; Cai, Xue-Fei; Zhang, Wen-Lu; Ren, Ji-Hua; Zhou, Li; Chen, Xiang; Chen, Ke; Li, Wan-Yu; Liu, Bo; Yang, Qiu-Xia; et al. (Oncotarget, 2016)
Keywords: Antineoplastic Agents - pharmacology; Apoptosis; Carcinoma, Hepatocellular - drug therapy; Carcinoma, Hepatocellular - metabolism; Cell Line, Tumor; Cell Separation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione S-Transferase pi - metabolism; Glycogen Synthase Kinase 3 - metabolism; Humans; Liver Neoplasms - drug therapy; Liver Neoplasms - metabolism; MAP Kinase Kinase 4 - metabolism; MAP Kinase Signaling System - drug effects; Niacinamide - analogs & derivatives; Niacinamide - pharmacology; Phenylurea Compounds - pharmacology; Research Paper; RNA, Messenger - metabolism; Signal Transduction; Sirtuin 3 - metabolism; c-Jun N-terminal kinase; drug sensitivity; glutathione S-transferase pi 1; hepatocellular carcinoma; SIRT3